374Water Inc. quarterly report, Q1 FY2022

Business Context and Reporting Period

374Water Inc. filed this unaudited Form 10-Q for the three months ended March 31, 2022. The company develops and commercializes AIRSCWO supercritical water oxidation systems intended to recover resources from waste and reduce waste byproducts. The company completed its reverse-merger transaction on April 16, 2021 and generated its first system-sale revenue during the current quarter.

Key Financial Metrics

MetricQ1 2022Q1 2021
Revenue$273,231$0
Cost of goods sold$247,986$0
Gross profit$25,245$0
Gross marginApproximately 9.2%Not applicable
Operating expenses$898,950$66,551
Loss from operations$(873,705)$(66,551)
Net loss$(872,858)$(66,551)
Net marginApproximately (319.6)%Not applicable
Net cash provided by operating activities$115,911$(4,022)
Cash at period end$11,243,795$72,598
  • Revenue arose primarily from the sale of the first AIRSCWO system to the Orange County Sanitation District, along with manufacturing, testing, consulting and advisory services.
  • Deferred revenue was $763,333 at March 31, 2022, and management expected all of it to be recognized within one year.
  • Working capital was $10.50 million, compared with $11.26 million at December 31, 2021.
  • Total assets were $12.46 million and total liabilities were $0.91 million. The filing does not report outstanding debt.
  • Stockholders’ equity was $11.55 million at March 31, 2022. The balance sheet reports an accumulated deficit of $4.03 million; the statement of stockholders’ equity presents a March 31 accumulated deficit of $3.88 million, so the filing contains an apparent presentation inconsistency that should be verified.
  • Research and development expense was $185,653, compensation and related expense was $301,235, professional fees were $150,658, and general and administrative expense was $261,403.

Material Changes Versus the Prior Comparable Period

  • Revenue increased from $0 to $273,231 as the company began commercial activity with its first AIRSCWO system sale.
  • Operating expenses increased to $898,950 from $66,551, driven by higher engineering and research activity, hiring and compensation, stock-based compensation, insurance, and legal and accounting costs associated with the merger and public-company obligations.
  • Net loss increased to $872,858 from $66,551.
  • Operating cash flow improved to $115,911 from negative $4,022, primarily because of $763,333 in deferred revenue and higher accounts payable and accrued expenses. This cash flow benefit may not be recurring.
  • Cash increased modestly from $11.13 million at year-end 2021 to $11.24 million at March 31, 2022.
  • The remaining 27,272 Series D preferred shares were converted into 1,363,149 common shares on January 12, 2022. Common shares outstanding increased to 126,680,895 from 125,317,746 at December 31, 2021.
  • Stock-based compensation increased to $97,558 from $10,433. The company had 12.66 million stock options outstanding and 1.25 million warrants outstanding at quarter-end.

Guidance, Outlook, Risks and Unusual Items

  • The company provided no quantitative revenue, earnings or production guidance.
  • Management stated that available cash should satisfy working-capital needs and financial obligations for at least the next 12 months from the report date.
  • The company remains dependent on successfully developing, manufacturing and commercializing AIRSCWO systems and has a limited operating and revenue history.
  • Risks identified include research and development execution, competition, patent protection and enforcement, political and economic conditions, interest-rate and market fluctuations, regulatory and legal changes, and tax and monetary policy changes.
  • The company has a Duke University license requiring royalties based on licensed product sales and sublicensing fees, as well as reimbursement of ongoing patent expenses. No license-related expense was incurred during the quarter.
  • The company incurred $50,000 of related-party expenses associated with manufacturing AIRSCWO systems through Merrell Bros. or affiliates.
  • Disclosure controls and internal control over financial reporting were reported as ineffective because of a material weakness involving inadequate entity-level controls, including an ineffective board structure and no audit committee. No auditor attestation report was required because the company is a smaller reporting company.
  • After quarter-end, shareholders approved a 2021 Equity Incentive Plan reserving up to 10 million common shares for awards.

Important Facts for Investors to Verify

  • Verify the terms, delivery status, remaining obligations and expected margin of the first AIRSCWO system sale, including the $763,333 deferred-revenue balance.
  • Assess whether the quarter’s positive operating cash flow reflects customer advances rather than sustainable operating profitability.
  • Reconcile the conflicting accumulated-deficit amounts presented in the balance sheet and statement of stockholders’ equity.
  • Monitor cash burn, additional financing requirements and management’s assertion that current liquidity covers at least 12 months.
  • Evaluate the impact of the 12.66 million options, 1.25 million warrants and newly authorized 10 million-share equity plan on future dilution.
  • Review remediation of the material weakness in internal controls and the absence of an audit committee.
  • Confirm the filing’s inconsistent reference to shares outstanding “as of March 31, 2021” in the cover page, versus the financial statements’ March 31, 2022 share count.